The Eisai Assistance Program
Visit eisaireimbursement.com or call 1-866-61-EISAI (1-866-613-4724)
Food and Drug Administration approved ibrutinib (Imbruvica, Pharmacyclics LLC) for pediatric patients
Seagen Product Information Update
NPPES and the NPI Registry
Many of you have noted the recent instability of NPPES and the NPI Registry. CMS has begun implementing changes that should eliminate the instability. We expect that these changes will be completed next week.